Senseonics Announces Transfer to Nasdaq Stock Exchange
Senseonics (SENS) will transfer its common stock listing from NYSE American to the Nasdaq Global Select Market, effective after market close on November 14, 2025. The company expects its shares to begin trading on Nasdaq under the existing ticker SENS on November 17, 2025. The move is described as a decision made in the best interest of the company and its stockholders and does not change the company ticker symbol.
Senseonics (SENS) trasferirà la quotazione delle sue azioni ordinarie da NYSE American al Nasdaq Global Select Market, con effetto dopo la chiusura di mercato di 14 novembre 2025. La società si aspetta che le sue azioni inizino a negoziare su Nasdaq sotto l'attuale ticker SENS il 17 novembre 2025. La mossa è descritta come una decisione presa nell'interesse superiore dell'azienda e dei suoi azionisti e non comporta alcuna modifica al simbolo di negoziazione dell'azienda.
Senseonics (SENS) transferirá su listado de acciones comunes desde NYSE American al Nasdaq Global Select Market, con efecto después del cierre del mercado el 14 de noviembre de 2025. La compañía espera que sus acciones comiencen a cotizar en Nasdaq bajo el ticker existente SENS el 17 de noviembre de 2025. El traslado se describe como una decisión tomada en el mejor interés de la empresa y de sus accionistas y no cambia el símbolo de cotización de la empresa.
Senseonics (SENS) 은 일반주 상장을 NYSE American에서 Nasdaq Global Select Market으로 이전하며, 시장 종가 이후 2025년 11월 14일에 발효됩니다. 회사는 주식이 SENS라는 기존 종목 기호로 2025년 11월 17일에 Nasdaq에서 거래를 시작할 것으로 기대합니다. 이 이동은 회사와 주주들의 최대 이익에 부합하는 결정으로 설명되며 회사의 티커 심볼은 변경되지 않습니다.
Senseonics (SENS) va transférer la cotation de ses actions ordinaires de NYSE American vers le Nasdaq Global Select Market, avec effet après la clôture du marché le 14 novembre 2025. La société prévoit que ses actions commenceront à être cotées sur Nasdaq sous le ticker existant SENS le 17 novembre 2025. Ce déplacement est décrit comme une décision prise dans l'intérêt supérieur de l'entreprise et de ses actionnaires et ne modifie pas le symbole boursier de l'entreprise.
Senseonics (SENS) wird seine Stammaktienliste vom NYSE American zum Nasdaq Global Select Market überführen, mit Wirkung nach Handelsschluss am 14. November 2025. Das Unternehmen erwartet, dass seine Aktien unter dem bestehenden Ticker SENS am 17. November 2025 an der Nasdaq gehandelt werden. Die Maßnahme wird als Entscheidung beschrieben, die im besten Interesse des Unternehmens und seiner Aktionäre getroffen wurde, und ändert das Tickersymbol des Unternehmens nicht.
Senseonics (SENS) سينقل إدراج أسهمه العادية من بورصة نيويورك الأمريكية (NYSE American) إلى سوق Nasdaq Global Select Market، ويبدأ ذلك بعد إغلاق السوق في 14 نوفمبر 2025. وتتوقع الشركة أن تبدأ أسهمها بالتداول في ناسداك تحت الرمز المتداول الحالي SENS في 17 نوفمبر 2025. وتُوصف الخطوة بأنها قرار اتُّخذ بما يخدم مصلحة الشركة ومساهميها ولا تغيّر الرمز التداولي للشركة.
- None.
- None.
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, has announced that as a decision in the best interest of the Company and its stockholders, it will transfer the listing of its common stock from the NYSE American to the Nasdaq Global Select Market (“Nasdaq”), effective after the market closes on November 14, 2025. The Company’s stock is expected to begin trading on Nasdaq under the existing ticker symbol “SENS” on November 17, 2025.
About Senseonics
Senseonics Holdings, Inc. ("Senseonics") is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
Forward Looking Statements
Any statements in this press release about the Company’s planned transfer to the Nasdaq Global Select Market and the expected timing thereof, and other statements containing the words "believe," “expect,” “intend,” “may,” “projects,” “will,” “planned,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: risks related to the timing and execution of the exchange transfer, potential market disruptions affecting trading of the Company’s common stock, other operational or strategic risks and such other factors as are set forth in the risk factors detailed in Senseonics' Annual Report on Form 10-K for the year ended December 31, 2024, the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 and future reports filed with the SEC under the heading "Risk Factors." In addition, the forward-looking statements included in this press release represent Senseonics’ views as of the date hereof. Senseonics anticipates that subsequent events and developments will cause Senseonics’ views to change. However, while Senseonics may elect to update these forward-looking statements at some point in the future, Senseonics specifically disclaims any obligation to do so except as required by law. These forward-looking statements should not be relied upon as representing Senseonics’ views as of any date subsequent to the date hereof.
Senseonics Investor Contact
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com
FAQ
When will Senseonics (SENS) start trading on Nasdaq?
When does Senseonics' (SENS) NYSE American listing end?
Will Senseonics (SENS) change its ticker symbol when moving to Nasdaq?
How might the transfer to Nasdaq affect Senseonics (SENS) shareholders?
Where can investors find the trading status for Senseonics (SENS) during the transfer week?
